Literature DB >> 3063552

Cardiac morbidity due to Chagas' disease in a rural community in Bolivia.

T Weinke1, K Ueberreiter, M Alexander.   

Abstract

The prevalence of cardiac morbidity due to Chagas' disease was assessed in a rural community in Central Bolivia. Sixty-nine of 104 persons (66%) were seropositive to Trypanosoma cruzi by two serological methods. Two of 35 (6%) seronegative individuals presented with modest ECG alterations (left anterior hemiblock), but 21 of 69 (30%) seropositives showed modest and severe abnormalities (6 complete right bundle branch block, 2 polyfocal or frequent extrasystoles, 9 ischaemic ST alterations). A high percentage (56%) of domiciliary Triatoma infestans was infected with T. cruzi. There was a significant association between seropositivity and substandard housing. Priority preventive measures should thus include house improvement (to reduce bug infestation) and health education.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3063552      PMCID: PMC2249411          DOI: 10.1017/s0950268800029538

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  12 in total

1.  Trypanosoma cruzi: zymodemes associated with acute and chronic Chagas' disease in central Brazil.

Authors:  A O Luquetti; M A Miles; A Rassi; J M de Rezende; A A de Souza; M M Póvoa; I Rodrigues
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

Review 2.  Diagnosis of African and American trypanosomiases.

Authors:  N Van Meirvenne; D Le Ray
Journal:  Br Med Bull       Date:  1985-04       Impact factor: 4.291

Review 3.  Control of Chagas' disease vectors.

Authors:  C J Schofield
Journal:  Br Med Bull       Date:  1985-04       Impact factor: 4.291

4.  Electrocardiographic classification and abbreviated lead system for population-based studies of Chagas' disease.

Authors:  J H Maguire; K E Mott; J A Souza; E C Almeida; N B Ramos; A C Guimarães
Journal:  Bull Pan Am Health Organ       Date:  1982

5.  [Distinctive features of the cardiomyopathy in Chagas disease].

Authors:  H A Palmero; T F Caeiro; D J Iosa
Journal:  Medicina (B Aires)       Date:  1980       Impact factor: 0.653

6.  Pathologic anatomy of the His-Tawara system and electrocardiographic abnormalities in chronic Chagas' heart disease.

Authors:  J A Mello de Oliveira; J S Meira Oliveira; F Köberle
Journal:  Arq Bras Cardiol       Date:  1972-02       Impact factor: 2.000

7.  The prognostic value of the electrocardiographic features of chronic Chagas' disease.

Authors:  J C Dias; K Kloetzel
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1968 May-Jun       Impact factor: 1.846

8.  Histopathology of the conducting tissue of the heart in Chagas' myocarditis.

Authors:  Z A Andrade; S G Andrade; G B Oliveira; D R Alonso
Journal:  Am Heart J       Date:  1978-03       Impact factor: 4.749

9.  Relationship of electrocardiographic abnormalities and seropositivity to Trypanosoma cruzi within a rural community in northeast Brazil.

Authors:  J H Maguire; K E Mott; J S Lehman; R Hoff; T M Muniz; A C Guimarães; I Sherlock; R H Morrow
Journal:  Am Heart J       Date:  1983-02       Impact factor: 4.749

10.  [Morbidity in Chagas' disease. III. Longitudinal study of 6 years, in Virgem da Lapa, MG, Brazil].

Authors:  J B Pereira; H P Willcox; J R Coura
Journal:  Mem Inst Oswaldo Cruz       Date:  1985 Jan-Mar       Impact factor: 2.743

View more
  3 in total

1.  Prevalence and epidemiological significance of Trypanosoma cruzi infection among Latin American immigrants in Berlin, Germany.

Authors:  M Frank; B Hegenscheid; K Janitschke; T Weinke
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

2.  Prevalence of Chagas heart disease in a region endemic for Trypanosoma cruzi: evidence from a central Bolivian community.

Authors:  Jessica E Yager; Daniel F Lozano Beltran; Faustino Torrico; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

Review 3.  Steps for preventing infectious diseases in women.

Authors:  Mirta Roses Periago; Ricardo Fescina; Pilar Ramón-Pardo
Journal:  Emerg Infect Dis       Date:  2004-11       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.